Groowe Groowe / Newsroom / SNY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SNY News

Sanofi American Depositary Shares (Each representing one-half of one ordinary share)

Continuous Bioprocessing Market Set to Surpass Valuation of US$ 2,331.98 Million By 2035 | Astute Analytica

globenewswire.com
AMGN LULU CAT REGN TMO BIIB GILD BMY MRK SNY

Allergy & Asthma Network Launches National Patient Advocacy Leadership Initiative (PALI)

prnewswire.com
AMGN AZN SNY REGN

Press Release: Myqorzo and Redemplo approved in China

globenewswire.com
SNY

House Dust Mite Disease Market to Exhibit Substantial Growth at a CAGR of 3.5% During the Forecast Period (2025-2034) | DelveInsight USA - English USA - English

prnewswire.com
ALKS STG GSK SNY TEVA AZN INCY REGN PFE BMY LLY AMGN ABBV GILD BIIB CSL VRTX BHC NVS MRK LEO ALLT CNTB INM

NFT in Healthcare Market Forecasts From USD 250 Mn in 2025 to USD 1,142.77 Mn by 2034 - Trends, Drivers & Strategic Outlook

globenewswire.com
HUM UNH PFE SNY

$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More

globenewswire.com
ADVM MAT SNY

Macrophage Activation Syndrome Market in the 6MM to Witness Upsurge in Growth at a CAGR of 24.7% During the Forecast Period (2025-2034) | DelveInsight

prnewswire.com
NVS BIIB VTRS UCB BMY ABBV REGN SNY LLY JNJ HOPE GCBC AMGN TAK

Inflammatory Diseases Biologics Market to Reach USD 157.31 Billion by 2033 as Targeted Immunology Therapies Redefine Long-Term Disease Control

prnewswire.com
AMGN NVS JNJ PFE GSK ABBV SNY LLY

diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy

prnewswire.com
BIIB AMGN LLY JNJ PFE MRK BMY GILD REGN AZN ABBV SNY NVO LULU GOOG MSFT AMZN META TSLA NVDA XOM CVX KO PEP MCD DIS BA CAT GS JPM BAC WFC C T VZ CMCSA NFLX ADBE CRM INTC QCOM AMD CSCO HON GE IBM ORCL SAP ACN MU AMAT LRCX ADI TXN NXPI MRVL MCHP PYPL CMG SBUX NKE HD PG UNH ELV CVS CI HCA MCK CAH

Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors

globenewswire.com
SNY